Challenges in the development of new therapies for bronchiectasis.
about
The EMBARC European Bronchiectasis Registry: protocol for an international observational studyRaising awareness of bronchiectasis in primary care: overview of diagnosis and management strategies in adults.Neutrophil Elastase Activity Is Associated with Exacerbations and Lung Function Decline in Bronchiectasis.The European Multicentre Bronchiectasis Audit and Research Collaboration (EMBARC): experiences from a successful ERS Clinical Research Collaboration.The Rationale and Evidence for Use of Inhaled Antibiotics to Control Pseudomonas aeruginosa Infection in Non-cystic Fibrosis Bronchiectasis.
P2860
Challenges in the development of new therapies for bronchiectasis.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Challenges in the development of new therapies for bronchiectasis.
@en
type
label
Challenges in the development of new therapies for bronchiectasis.
@en
prefLabel
Challenges in the development of new therapies for bronchiectasis.
@en
P2860
P1476
Challenges in the development of new therapies for bronchiectasis.
@en
P2093
James D Chalmers
Michael Loebinger
P2860
P304
P356
10.1517/14656566.2015.1019863
P407
P577
2015-04-01T00:00:00Z